Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2004-004921-89-GB
EUCTR2004-004921-89-GB
Active, not recruiting
Phase 1

Improving diagnosis and treatment of attention deficits in head injured patients - Pharmacological treatment for head injured patients

orth Bristol NHS Trust0 sites20 target enrollmentFebruary 15, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAttention difficulties after closed head injury
DrugsEquasymEdronaxProvigil

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Attention difficulties after closed head injury
Sponsor
orth Bristol NHS Trust
Enrollment
20
Status
Active, not recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
orth Bristol NHS Trust

Eligibility Criteria

Inclusion Criteria

  • •6\+ months post closed head injury, persistent attention difficulties, good recovery (Glasgow Outcome Scale equal to 5\)
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •History of neurological/psychiatric disorder, drug abuse, cardiac arrhytmia, high blood pressure

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Remediating attention deficits in children with sensory processing dysfunctioSensory processing dysfunctionMental and Behavioural Disorders
ISRCTN10912124niversity of California, San Francisco65
Not yet recruiting
Phase 1
Attempts to improve attention function through mindful trainingADHD tendencynone
JPRN-jRCT1060220048Hashimoto Tadayuki210
Completed
Phase 3
Management of Attention - Deficit / Hyperactivity Disorder (ADHD) in Childern through AYURVEDA
CTRI/2019/01/017327Director IPGT and RA GAU Jamnagar40
Active, not recruiting
Phase 1
Cognitive remediation and Attention Deficit Disorder with or without Hyperactivity (ADHD)Attention Deficit Disorder with or without HyperactivityMedDRA version: 16.0Level: HLTClassification code 10003730Term: Attention deficit and disruptive behaviour disordersSystem Organ Class: 100000004873Therapeutic area: Body processes [G] - Bones and nerves physological processes [G11]
EUCTR2012-004586-41-FRCHU de Bordeaux60
Completed
Not Applicable
Attention rehabilitation for anxious patientsAnxiety Disorders.Generalized anxiety disorderF41.1
IRCT20230617058502N1Islamic Azad University of Shiraz30